FRGT (FRGT) Stock Price & Analysis
FRGT (FRGT) fell 1.83% to USD 1.07 as of September 8, 2026 at 03:31 UTC, according to Nexqual real-time market data.
FRGT last closed at USD 1.07; the session ranged USD 1.02–1.09 on volume of 63,367 shares. Market capitalization is —, with a 52-week range of USD 1.02–51.5 (NCM). Source: Nexqual, September 8, 2026 at 03:31 UTC.
Key Statistics (as of September 8, 2026 at 03:31 UTC)
| Price | USD 1.07 |
|---|---|
| Change | ▼ 1.83% (down) |
| Previous Close | USD 1.07 |
| Open | USD 1.07 |
| Day Range | USD 1.02 – 1.09 |
| 52-Week Range | USD 1.02 – 51.5 |
| Volume | 63,367 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (FRGT)
Nexqual's technical model rates FRGT "SELL" based on 2 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 03:31 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 23.2 (oversold) |
| vs SMA50 | Below (USD 2.83) |
| MACD | -0.48 (negative) |
From FRGT's Latest SEC 10-K Filing (filed 2025-04-14)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SPRC | SciSparc Ltd. | USD 5.29 | ▼ 9.57% |
| TGL | Treasure Global Inc. | USD 2.42 | ▼ 2.81% |
| CDIO | Cardio Diagnostics Holdings Inc | USD 1.86 | ▲ 1.09% |
| FOXOD | FOXO Technologies Inc. | USD 0.15 | ▲ 50.03% |
| BDRX | Biodexa Pharmaceuticals plc | USD 0.85 | ▲ 8.03% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 03:31 UTC. This page is informational and not investment advice.